Anika Therapeutics (NASDAQ:ANIK) Director John Henneman III Buys 5,000 Shares
Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) Director John Henneman III acquired 5,000 shares of the stock in a transaction on Friday, May 1st. The shares were acquired at an average price of $14.66 per share, with a total value of $73,300.00. Following the transaction, the director...